Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $41,517 | 7 | 56.1% |
| Unspecified | $23,400 | 3 | 31.6% |
| Travel and Lodging | $7,284 | 16 | 9.8% |
| Food and Beverage | $1,843 | 33 | 2.5% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $23,401 | 15 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $23,400 | 3 | $0 (2018) |
| Alkermes, Inc. | $8,557 | 8 | $0 (2017) |
| Merck Sharp & Dohme LLC | $6,958 | 10 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $5,264 | 6 | $0 (2019) |
| JAZZ PHARMACEUTICALS INC. | $3,600 | 9 | $0 (2019) |
| Boehringer Ingelheim International GmbH | $2,660 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104.95 | 2 | $0 (2022) |
| ITI, Inc. | $56.74 | 1 | $0 (2023) |
| Janssen Global Services, LLC | $42.74 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $196.84 | 2 | Boehringer Ingelheim International GmbH ($140.10) |
| 2022 | $8,073 | 12 | Merck Sharp & Dohme LLC ($6,958) |
| 2021 | $1,470 | 1 | Boehringer Ingelheim International GmbH ($1,470) |
| 2019 | $27,073 | 27 | Janssen Research & Development, LLC ($23,401) |
| 2018 | $9,440 | 2 | ACADIA Pharmaceuticals Inc ($9,400) |
| 2017 | $27,791 | 15 | ACADIA Pharmaceuticals Inc ($14,000) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $56.74 | General |
| Category: PSYCHIATRY | ||||||
| 02/16/2023 | Boehringer Ingelheim International GmbH | — | Food and Beverage | In-kind items and services | $140.10 | General |
| 08/01/2022 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $5,115.00 | General |
| 08/01/2022 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 07/20/2022 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $188.65 | General |
| 07/20/2022 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $157.21 | General |
| 07/20/2022 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $63.78 | General |
| 07/20/2022 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $56.25 | General |
| 07/20/2022 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $54.41 | General |
| 07/19/2022 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $763.22 | General |
| 07/19/2022 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $261.83 | General |
| 07/19/2022 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $147.44 | General |
| 02/23/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $65.37 | General |
| 02/21/2022 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 11/15/2021 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $1,470.00 | General |
| 03/19/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: NEUROLOGY | ||||||
| 03/19/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Travel and Lodging | Cash or cash equivalent | $21.97 | General |
| Category: NEUROLOGY | ||||||
| 03/15/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | Cash or cash equivalent | $43.48 | General |
| Category: NEUROLOGY | ||||||
| 03/15/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | Cash or cash equivalent | $30.43 | General |
| Category: NEUROLOGY | ||||||
| 03/15/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| Category: NEUROLOGY | ||||||
| 03/15/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| Category: NEUROLOGY | ||||||
| 03/14/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Travel and Lodging | Cash or cash equivalent | $456.28 | General |
| Category: NEUROLOGY | ||||||
| 03/14/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Travel and Lodging | Cash or cash equivalent | $183.05 | General |
| Category: NEUROLOGY | ||||||
| 03/14/2019 | JAZZ PHARMACEUTICALS INC. | XYREM (Drug) | Food and Beverage | Cash or cash equivalent | $88.75 | General |
| Category: NEUROLOGY | ||||||
| 03/06/2019 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $19,991.95 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ACP-103-035 | ACADIA Pharmaceuticals Inc | $9,400 | 1 |
| ACP-103-034 | ACADIA Pharmaceuticals Inc | $8,000 | 1 |
| ACP-103-038 | ACADIA Pharmaceuticals Inc | $6,000 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 339 | 506 | $119,415 | $36,928 |
| 2022 | 4 | 279 | 441 | $105,690 | $35,047 |
| 2021 | 5 | 298 | 354 | $87,450 | $30,369 |
| 2020 | 4 | 205 | 219 | $66,605 | $18,055 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 185 | $42,550 | $15,990 | 37.6% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 128 | 226 | $42,940 | $11,426 | 26.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 49 | 50 | $27,500 | $6,785 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 32 | $4,800 | $2,228 | 46.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 13 | $1,625 | $499.87 | 30.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 175 | $40,250 | $16,243 | 40.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 114 | 201 | $38,190 | $10,706 | 28.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 45 | 45 | $24,750 | $6,655 | 26.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 19 | 20 | $2,500 | $1,443 | 57.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 69 | 70 | $38,500 | $10,652 | 27.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 81 | $18,150 | $8,086 | 44.6% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 102 | 130 | $22,100 | $6,865 | 31.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 37 | 43 | $6,450 | $3,448 | 53.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 29 | 30 | $2,250 | $1,317 | 58.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 76 | 77 | $42,350 | $8,806 | 20.8% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 59 | 66 | $9,900 | $3,452 | 34.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 43 | $9,460 | $3,233 | 34.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 32 | 33 | $4,895 | $2,564 | 52.4% |
About Dr. Eric Lenze, MD
Dr. Eric Lenze, MD is a Geriatric Psychiatry healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619941846.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Lenze, MD has received a total of $74,044 in payments from pharmaceutical and medical device companies, with $196.84 received in 2023. These payments were reported across 59 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($41,517).
As a Medicare-enrolled provider, Lenze has provided services to 1,121 Medicare beneficiaries, totaling 1,520 services with total Medicare billing of $120,400. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Geriatric Psychiatry
- Other Specialties Psychiatry
- Location Saint Louis, MO
- Active Since 02/15/2006
- Last Updated 04/17/2025
- Taxonomy Code 2084P0805X
- Entity Type Individual
- NPI Number 1619941846
Products in Payments
- NUPLAZID (Drug) $23,400
- XYREM (Drug) $3,600
- CAPLYTA (Drug) $56.74
- OFEV (Drug) $39.58
- INVEGA SUSTENNA (Drug) $29.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Psychiatry Doctors in Saint Louis
Dr. Vadim Baram, Md, MD
Geriatric Psychiatry — Payments: $1.7M
George Grossberg, Md, MD
Geriatric Psychiatry — Payments: $417,080
Sameer Arain, Md, MD
Geriatric Psychiatry — Payments: $8,394
Dr. Nezar El-Ruwie, M.d, M.D
Geriatric Psychiatry — Payments: $372.93
William Irvin, Md, MD
Geriatric Psychiatry — Payments: $259.00
Daniel Loiterstein, M.d, M.D
Geriatric Psychiatry — Payments: $99.89